The Health 202: Why the medical community is concerned about a genetic testing boom
The FDA’s move to allow 23andMe to screen people for breast cancer risks may unleash a flood of new direct-to-consumer genetic tests.
Related articles
-
Oregon, OSU, Georgia, Miami top 1st CFP rankings
November 6, 2024 -
U.S. man accused of spying by Russia says he was hurt in prison
August 23, 2019
